ViroGates A/S (VIRO) - Cash Flow Conversion Efficiency

Latest as of March 2026: -0.222x

Based on the latest financial reports, ViroGates A/S (VIRO) has a cash flow conversion efficiency ratio of -0.222x as of March 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (Dkr-3.73 Million ≈ $-584.37K USD) by net assets (Dkr16.79 Million ≈ $2.63 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see ViroGates A/S (VIRO) total market value for the company's overall valuation and market capitalisation.

ViroGates A/S - Cash Flow Conversion Efficiency Trend (2015–2025)

This chart illustrates how ViroGates A/S's cash flow conversion efficiency has evolved over time, based on yearly financial data.

ViroGates A/S Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of ViroGates A/S ranked by their cash flow conversion efficiency. See cash flow to debt ratio of ViroGates A/S to evaluate how effectively operating cash flow covers total debt obligations.

Company	Cash Flow Conversion Efficiency
T3 Defense Inc. NYSE:DFNS	-0.023x
SDN Company. Ltd KQ:099220	-0.004x
Ambitions Enterprise Management Co. L.L.C Class A Ordinary Shares NASDAQ:AHMA	0.032x
DELPHI WORLD MONEY LIMITED NSE:DELPHIFX	0.271x
Aurora Labs Ltd AU:A3D	-1.442x
Air Industries Group NYSE MKT:AIRI	0.000x
Vakif Menkul Kiymet Yatirim Ortakligi AS IS:VKFYO	-0.031x
Glennon Small Companies Ltd AU:GC1	0.011x

Annual Cash Flow Conversion Efficiency for ViroGates A/S (2015–2025)

The table below shows the annual cash flow conversion efficiency of ViroGates A/S from 2015 to 2025. View ViroGates A/S (VIRO) share price today for real-time trading data and today's change.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	Dkr19.40 Million ≈ $3.04 Million	Dkr-4.12 Million ≈ $-645.39K	-0.213x	+80.79%
2024-12-31	Dkr10.79 Million ≈ $1.69 Million	Dkr-11.95 Million ≈ $-1.87 Million	-1.107x	-54.56%
2023-12-31	Dkr17.01 Million ≈ $2.66 Million	Dkr-12.18 Million ≈ $-1.91 Million	-0.716x	+19.30%
2022-12-31	Dkr16.09 Million ≈ $2.52 Million	Dkr-14.28 Million ≈ $-2.23 Million	-0.887x	+32.01%
2021-12-31	Dkr16.43 Million ≈ $2.57 Million	Dkr-21.44 Million ≈ $-3.35 Million	-1.305x	-161.93%
2020-12-31	Dkr31.31 Million ≈ $4.90 Million	Dkr-15.60 Million ≈ $-2.44 Million	-0.498x	-16.38%
2019-12-31	Dkr42.22 Million ≈ $6.60 Million	Dkr-18.07 Million ≈ $-2.83 Million	-0.428x	-59.46%
2018-12-31	Dkr61.01 Million ≈ $9.55 Million	Dkr-16.38 Million ≈ $-2.56 Million	-0.268x	+87.07%
2017-12-31	Dkr3.00 Million ≈ $468.90K	Dkr-6.22 Million ≈ $-973.79K	-2.077x	-179.46%
2016-12-31	Dkr8.98 Million ≈ $1.41 Million	Dkr-6.68 Million ≈ $-1.04 Million	-0.743x	-60.13%
2015-12-31	Dkr14.39 Million ≈ $2.25 Million	Dkr-6.68 Million ≈ $-1.04 Million	-0.464x	--

About ViroGates A/S

CO:VIRO Denmark Medical Devices

Market Cap

$14.67 Million

Dkr93.75 Million DKK

Market Cap Rank

#26151 Global

#119 in Denmark

Share Price

Dkr10.10

Change (1 day)

-5.61%

52-Week Range

Dkr9.05 - Dkr17.40

All Time High

Dkr238.00